Bushen Wenyang Huayu Decoction Targets TLR4/NF-κB Mediated Autophagy to Treat Endometriosis Effectively

• Published in: Evidence-based complementary and alternative medicine 2022-11, Vol.2022, p.1-11
• Main Authors: Li, Ying, Meng, Xin, Fu, Xinping, An, Mingli, Liu, Huimin, Ma, Yiming, Li, Qingxue, Hao, Guorong, Ma, Yucong, Zhang, Yu, Yang, Jian, Chen, Jingwei
• Format: Article
• Language: English
• Subjects: Abdomen; Antibodies; Autografts; Autophagy; Drug dosages; Endometriosis; Immunofluorescence; Medical research; NF-κB protein; Pharmaceuticals; Polymerase chain reaction; Signal transduction; TLR4 protein; Toll-like receptors; Uterus; Western blotting
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2022/4263417

Endometriosis has been found to be closely related to autophagy. This study aimed to elucidate the possible mechanism of Bushen Wenyang Huayu Decoction (BWHD) in treating endometriosis (EMs) by targeting TLR4/NF-κB-mediated autophagy. Autologous grafting was used to generate the EMs model in rats. Once the model was developed, BWHD high-dose and low-dose groups received intragastric administration of BWHD, and the gestrinone group served as a positive control. Immunofluorescence labeling and Western blotting were used for the protein expression of toll-like receptor 4 (TLR4), nuclear transcription factor-κB (NF-κB), Beclin-1, and selective autophagy connector protein P62 (P62). Quantitative real-time polymerase chain reaction (qRT-PCR) was used to analyze mRNA levels of TLR4, NF-κB, Beclin-1, and P62. We found that BWHD significantly reduced the size of ectopic lesions in rats with EMs, regulated reproductive hormone levels, and alleviated the cell autophagy level. It suggested that BWHD could be an effective treatment of EMs by targeting TLR4/NF-κB signaling pathway.